JP2024508886A5 - - Google Patents
Info
- Publication number
- JP2024508886A5 JP2024508886A5 JP2023553225A JP2023553225A JP2024508886A5 JP 2024508886 A5 JP2024508886 A5 JP 2024508886A5 JP 2023553225 A JP2023553225 A JP 2023553225A JP 2023553225 A JP2023553225 A JP 2023553225A JP 2024508886 A5 JP2024508886 A5 JP 2024508886A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- oligonucleotide
- vedotin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156869P | 2021-03-04 | 2021-03-04 | |
| US63/156,869 | 2021-03-04 | ||
| PCT/US2022/018855 WO2022187586A1 (en) | 2021-03-04 | 2022-03-04 | Enhanced targeting using antibody-oligonucleotide conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508886A JP2024508886A (ja) | 2024-02-28 |
| JP2024508886A5 true JP2024508886A5 (https=) | 2025-03-11 |
Family
ID=83155559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553225A Pending JP2024508886A (ja) | 2021-03-04 | 2022-03-04 | 抗体－オリゴヌクレオチドコンジュゲートを使用した標的化の増強 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240307548A1 (https=) |
| EP (1) | EP4301859A4 (https=) |
| JP (1) | JP2024508886A (https=) |
| CN (1) | CN117715942A (https=) |
| WO (1) | WO2022187586A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| WO2025034978A1 (en) * | 2023-08-09 | 2025-02-13 | Code Biotherapeutics, Inc. | Enhanced dna dendrimers and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019148410A1 (en) * | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1 antibodies |
| EP3807644A4 (en) * | 2018-06-12 | 2022-07-06 | Angiex, Inc. | ANTIBODY-OLIGONUCLEOTIDE CONJUGATES |
-
2022
- 2022-03-04 EP EP22764114.9A patent/EP4301859A4/en not_active Withdrawn
- 2022-03-04 WO PCT/US2022/018855 patent/WO2022187586A1/en not_active Ceased
- 2022-03-04 CN CN202280032791.9A patent/CN117715942A/zh active Pending
- 2022-03-04 JP JP2023553225A patent/JP2024508886A/ja active Pending
- 2022-03-04 US US18/279,938 patent/US20240307548A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11993663B2 (en) | Low-viscosity antigen binding proteins and methods of making them | |
| US20240218036A1 (en) | Multi specific molecules | |
| CN114231512B (zh) | 半胱氨酸蛋白酶 | |
| JP2024508886A5 (https=) | ||
| US11119096B2 (en) | Universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples | |
| US20180280539A1 (en) | Systems and methods for nucleic acid expression in vivo | |
| AU2018290272A1 (en) | Heterodimeric bispecific antibodies | |
| US12121587B1 (en) | Dimeric antibodies | |
| US12116410B1 (en) | Methods of manufacturing dimeric antibodies | |
| CN107532158A (zh) | 半胱氨酸蛋白酶 | |
| JP2017522384A5 (https=) | ||
| JP2022191210A5 (https=) | ||
| JP2023537131A5 (https=) | ||
| JP2024532726A5 (https=) | ||
| US20240307548A1 (en) | Enhanced targeting using antibody-oligonucleotide conjugates | |
| US20250206847A1 (en) | Dimeric antibodies and their methods of manufacture | |
| US20180194859A1 (en) | Linked Dual Antibodies Conjugated at a Hinge Region | |
| JP2023535842A5 (https=) | ||
| US20240076381A1 (en) | Fcrn binding polypeptides | |
| EP4659022A1 (en) | System and method for analyzing antibody co-formulations | |
| WO2024220732A1 (en) | Endoglycosidase s2 (endos2) mutants and uses thereof | |
| NZ743923B2 (en) | Chimeric proteins and methods of immunotherapy | |
| EA043899B1 (ru) | Антигенсвязывающие белки, характеризующиеся низкой вязкостью, и способы их получения |